Date: Tuesday 29th June 2021 Time: 14:00 - 15:00 BST Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies. What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
Overview
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
Registration
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here. Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
Speaker details
Speaker
Biography
Steven Bailey Pfizer
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing.
Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit.
Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society.
Scientific Meetings
PSI Pre-Clinical SIG Webinar: Update from the Carcinogenicity working group
Date: Tuesday 29th June 2021 Time: 14:00 - 15:00 BST Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies. What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
Overview
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
Registration
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here. Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
Speaker details
Speaker
Biography
Steven Bailey Pfizer
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing.
Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit.
Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society.
Training Courses
PSI Pre-Clinical SIG Webinar: Update from the Carcinogenicity working group
Date: Tuesday 29th June 2021 Time: 14:00 - 15:00 BST Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies. What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
Overview
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
Registration
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here. Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
Speaker details
Speaker
Biography
Steven Bailey Pfizer
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing.
Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit.
Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society.
Journal Club
PSI Pre-Clinical SIG Webinar: Update from the Carcinogenicity working group
Date: Tuesday 29th June 2021 Time: 14:00 - 15:00 BST Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies. What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
Overview
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
Registration
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here. Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
Speaker details
Speaker
Biography
Steven Bailey Pfizer
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing.
Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit.
Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society.
Webinars
PSI Pre-Clinical SIG Webinar: Update from the Carcinogenicity working group
Date: Tuesday 29th June 2021 Time: 14:00 - 15:00 BST Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies. What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
Overview
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
Registration
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here. Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
Speaker details
Speaker
Biography
Steven Bailey Pfizer
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing.
Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit.
Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society.
Careers Meetings
PSI Pre-Clinical SIG Webinar: Update from the Carcinogenicity working group
Date: Tuesday 29th June 2021 Time: 14:00 - 15:00 BST Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies. What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
Overview
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
Registration
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here. Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
Speaker details
Speaker
Biography
Steven Bailey Pfizer
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing.
Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit.
Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society.
Upcoming Events
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
PSI Training Course: Regulatory Guidelines for Statisticians
This 2-day course is designed to provide a comprehensive understanding of the regulatory guidelines affecting statisticians in the pharmaceutical industry, including the latest updates in the field. The course will cover key International Council for Harmonisation (ICH) guidelines and other key regional regulatory agency documents.
In this event, we’ll start with a general introduction to hierarchical composite endpoints and an overview of common analysis methods including win ratio, win odds, and net benefit. Then, the practical considerations will be illustrated through case studies from clinical trials in heart failure and chronic kidney disease. We conclude with a discussion and a Q&A.
Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Senior Medical Statistician & Statistical Programmer
An exciting opportunity has arisen for a Senior Medical Statistician & Statistical Programmer to join the UKCRC fully registered Derby Clinical Trials Support Unit (Derby CTSU).
Statisticians in the Pharmaceutical Industry Executive Office: c/o MCI UK Ltd | Unit 24/22 South | Building 4000 | Langstone Park| Langstone Road | Havant | PO9 1SA | UK